Tsuyoshi Shirai (T Shirai)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Rheumatoid Arthritis

Polycyclic Aromatic Hydrocarbons

Pulmonary Arterial Hypertension

Top Venues

Modern rheumatology case reports

Clinical rheumatology

Rheumatology international

Case reports in rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports 8 (2) (2024)
Isso Saito, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Enthesitis as an initial presentation of vascular Behçet's syndrome: a case-based review. Rheumatology international (2024)
Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports 8 (2) (2024)
Maya Yamato, Tsuyoshi Shirai, Yusho Ishii, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus. Clinical rheumatology 43 (3) (2024)
Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports (2024)
Maya Yamato, Tsuyoshi Shirai, Yusho Ishii, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus. Clinical rheumatology (2024)
Soshi Okazaki, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis. Modern rheumatology case reports 8 (2) (2024)
Maya Yamato, Tsuyoshi Shirai, Yusho Ishii, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus. Clinical rheumatology 43 (3) (2024)
Sae Shirota, Tsuyoshi Shirai, Kentaro Mori, Jun Inoue, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Comment on: A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan. Rheumatology (Oxford, England) (2023)
Tsuyoshi Shirai, Satoshi Watanabe, Natsuko O Shinozaki, Kairi Baba, Hiroyuki Yamasaki, Tomonori Ishii, Hiroshi Fujii
Common dysbiosis features between patients of different social environments in Takayasu arteritis: Comments on the article by Fan et al. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Tokio Katakura, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Successful management of interstitial lung disease in dermatomyositis complicated by malignancy: a case-based review. Rheumatology international (2023)
Maya Yamato, Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
First reported case of pulmonary arteritis in patients with relapsing polychondritis. Rheumatology (Oxford, England) (2023)
Tsuyoshi Shirai, Jun Suzuki, Shimpei Kuniyoshi, Yuito Tanno, Hiroshi Fujii
Granulomatosis with Polyangiitis Following Pfizer-BioNTech COVID-19 Vaccination. Modern rheumatology case reports (2022)
Kae Ishii, Tsuyoshi Shirai, Yoichi Kakuta, Tomoaki Machiyama, Hiroko Sato, Tomonori Ishii, Hideo Harigae, Hiroshi Fujii
Development of severe colitis in Takayasu arteritis treated with tocilizumab. Clinical rheumatology 41 (6) (2022)
Tomoyuki Mutoh, Taichi Nagai, Tsuyoshi Shirai, Soshi Okazaki, Hiroko Sato, Hiroshi Fujii
Predictive factors for retention of golimumab over a median 4-year duration in Japanese patients with rheumatoid arthritis in a real-world setting: A retrospective study and literature review. International journal of rheumatic diseases 25 (3) (2022)
Tsuyoshi Shirai, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
Dysbiosis in Takayasu arteritis complicated with infectious endocarditis following tocilizumab administration. Scandinavian journal of rheumatology (2022)
Chikaho Akiyama, Tsuyoshi Shirai, Hiroko Sato, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae
Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy. Rheumatology international (2021)
Yusho Ishii, Hiroshi Fujii, Koichiro Sugimura, Tsuyoshi Shirai, Yosuke Hoshi, Yoko Fujita, Yuko Shirota, Tomonori Ishii, Hiroaki Shimokawa, Hideo Harigae
Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody. Case reports in rheumatology 2020 (2020)
Tomoyuki Mutoh, Tsuyoshi Shirai, Tomonori Ishii, Yuko Shirota, Fumiyoshi Fujishima, Fumiaki Takahashi, Yoichi Kakuta, Yoshitake Kanazawa, Atsushi Masamune, Yoshikatsu Saiki, Hideo Harigae, Hiroshi Fujii
Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nature communications 11 (1) (2020)
Tomoyuki Mutoh, Tsuyoshi Shirai, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae
Insufficient Use of Corticosteroids without Immunosuppressants Results in Higher Relapse Rates in Takayasu Arteritis. The Journal of rheumatology 47 (2) (2019)
Yusho Ishii, Tsuyoshi Shirai, Yousuke Hoshi, Yoko Fujita, Yuko Shirota, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae
Nasal Septal Perforation in Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Case reports in rheumatology 2018 (2018)